Sort   by:  
 Page size 
UnknownCONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials.
Not available
S-EPMC11773258 | biostudies-literature
UnknownIdentification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.
Not available
S-EPMC3832790 | biostudies-literature
UnknownTelomere length shows no association with BRCA1 and BRCA2 mutation status.
Not available
S-EPMC3906069 | biostudies-literature
UnknownFunctional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers.
Not available
S-EPMC3617380 | biostudies-literature
UnknownTargeted prostate cancer screening in BRCA1 and BRCA2 mutation carriers: results from the initial screening round of the IMPACT study.
Not available
S-EPMC4105321 | biostudies-literature
UnknownGenome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types.
Not available
S-EPMC5010513 | biostudies-literature
UnknownLiraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Not available
S-EPMC4985288 | biostudies-literature
UnknownLong-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Not available
S-EPMC3596060 | biostudies-literature
UnknownGlobal Burden of Cardiovascular Diseases and Risks, 1990-2022.
Not available
S-EPMC7615984 | biostudies-literature
Sort   by:  
 Page size